As of Feb 24
| -5.75 / -7.18%|
The 3 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 78.00, with a high estimate of 89.00 and a low estimate of 69.00. The median estimate represents a +4.91% increase from the last price of 74.35.
The current consensus among 5 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.